Apple Inc. vs. BIOGAIA AB S/ADR
BIOGAIA AB S/ADR (BIOGY) comes out ahead, leading on 1 of 1 compared factors.
Size & Scale
| AAPL | BIOGY | |
|---|---|---|
| Market Cap | $4.51 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | — |
AAPL and BIOGY split the size & scale factors evenly.
Valuation
| AAPL | BIOGY | |
|---|---|---|
| P/E Ratio | 35.59 | — |
| Price / Book | 41.99 | — |
| Price / Sales | 9.67 | — |
AAPL and BIOGY split the valuation factors evenly.
Profitability
| AAPL | BIOGY | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | — |
AAPL and BIOGY split the profitability factors evenly.
Dividend
| AAPL | BIOGY | |
|---|---|---|
| Dividend Yield | 0.35% | 3.40% |
| Payout Ratio | 12.39 | — |
BIOGY leads on 1 of 1 dividend factors.
Risk & Sentiment
| AAPL | BIOGY | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and BIOGY split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, BIOGY overview, BIOGY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.